Efficacy of treatment with terlipressin plus albumin in hepatorenal syndrome diagnosed with the new acute kidney injury versus the conventional criteria

Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1292-1294. doi: 10.1097/MEG.0000000000001460.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Kidney Injury / complications
  • Acute Kidney Injury / diagnosis*
  • Acute Kidney Injury / drug therapy*
  • Acute Kidney Injury / mortality
  • Albumins / therapeutic use*
  • Drug Therapy, Combination
  • Hepatorenal Syndrome / diagnosis*
  • Hepatorenal Syndrome / drug therapy*
  • Hepatorenal Syndrome / etiology
  • Hepatorenal Syndrome / mortality
  • Humans
  • Kaplan-Meier Estimate
  • Practice Guidelines as Topic
  • Retrospective Studies
  • Terlipressin / therapeutic use*
  • Treatment Outcome
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Albumins
  • Vasoconstrictor Agents
  • Terlipressin